SBRI: Overdose detection, response and intervention - Phase 2

Description

***THIS IS AN AWARD NOTICE TO CONCLUDE THE PRE-COMMERCIAL PROCUREMENT OF THE COMPETITION DETAILED BELOW. THIS IS NOT A NEW COMPETITION. THE COMPETITION WAS ADVERTISED AND ADMINISTERED BY INNOVATE UK AND CONTRACTS HAVE BEEN AWARDED.*** This Small Business Research Initiative (SBRI) award funded Phase 2 R&D contracts to develop working prototypes in relation to disruptive, innovative solutions that focus on detecting, responding to, and intervening in, early acute risk of non-fatal and fatal overdose. This is a Pre-Commercial Procurement funded by the Office for Life Sciences (OLS) and the Chief Science Office (CSO). The test environment is provided by at least one of the research partners listed below: - Health Innovation South East Scotland - South London Academic Health Science Network - South London Health Innovation Network - West of Scotland Innovation Hub - Welsh Ambulance Services NHS Trust - Scottish Ambulance Services - North of Scotland Innovation Hub **THIS IS AN AWARD NOTICE TO CONCLUDE THE PRE-COMMERCIAL PROCUREMENT OF THE COMPETITION DETAILED BELOW. THIS IS NOT A NEW COMPETITION. THE COMPETITION WAS ADVERTISED AND ADMINISTERED BY INNOVATE UK AND CONTRACTS HAVE BEEN AWARDED.*** Contracts are between NHS Golden Jubilee and winning participants. Phase 2 projects range in size up to total costs of 500,000 GBP inclusive of VAT. The aim of this award is speed up and improve the detection of, response to and intervention in potentially fatal overdoses using innovative digital technologies and therapeutic solutions. The projects focus on one or more of the following priorities: - discrete digital technology solutions with intuitive and simple design focussed on service users and responders - simple alert or responder pathways that create effective responses to potentially fatal overdose events - enhance the ability to self-monitor by people who use drugs - improved equity of access, detection and response in this vulnerable population through connected and safe digitalised platforms - enhanced simple live intelligent data gathering processes, surveillance and remote monitoring - enhance innovative intervention therapeutics as antidotes to overdose episodes Any adoption and implementation of a solution from this competition would be subject to a separate, possibly competitive, procurement exercise. This competition does not cover the purchase of any solution. Contracts have be given to successful applicants